News
MRK
75.97
-2.16%
-1.68
Weekly Report: what happened at MRK last week (0505-0509)?
Weekly Report · 1h ago
Biggest stock movers Monday: Magnificent Seven, and more
Seeking Alpha · 1h ago
Trump's New Drug Pricing Executive Order Could Rattle Pharma Stocks, With Price Cuts Of Up To 80%: Novo Nordisk, Pfizer And J&J Fall In Premarket
Benzinga · 2h ago
High-Quality Dividend Growth Stocks Near 52-Week Lows: Alphabet Is Astounding
Seeking Alpha · 5h ago
Trump says he’ll sign executive order to lower prescription-drug prices
MarketWatch · 11h ago
Notable healthcare headlines for the week: Viatris, Novavax and UnitedHealth in focus
Seeking Alpha · 21h ago
Invesco Growth And Income Fund Q1 2025 Commentary
Seeking Alpha · 1d ago
Salesforce, IBM share losses contribute to Dow's 100-point drop
MarketWatch · 2d ago
Measles cases top 1K in the U.S. in 2025
Seeking Alpha · 2d ago
Dow's 115-point rally highlighted by gains in Chevron, Boeing stocks
MarketWatch · 2d ago
MOAT ETF is up 10% in 2 weeks. Is this ASX ETF still good value?
The Motley Fool · 3d ago
Hartford Equity Income Fund Q1 2025 Commentary
Seeking Alpha · 3d ago
FDA to speed up AI rollout to accelerate drug reviews
Seeking Alpha · 3d ago
Hartford Healthcare Fund Q1 2025 Commentary
Seeking Alpha · 3d ago
Are Your Health Care ETFs Safe? Trump's New Policies May Trigger Shockwaves Across Pharma Stocks
Benzinga · 3d ago
A Look at Pharma ETFs After Strong Q1 Earnings
NASDAQ · 3d ago
Merck boosts U.S. investments with $895M expansion in Kansas site
Seeking Alpha · 3d ago
BeiGene, Ltd., Soon To Be BeOne Medicines: New Name And New Profit
Seeking Alpha · 3d ago
Merck Sets $895 Million Animal-Health Investment in Kansas
Dow Jones · 3d ago
2 Beaten-Down Stocks That Are Great Buys on the Dip
The Motley Fool · 3d ago
More
Webull provides a variety of real-time MRK stock news. You can receive the latest news about Merck & Co through multiple platforms. This information may help you make smarter investment decisions.
About MRK
More
Merck & Co., Inc. is a global health care company that delivers health solutions through its prescription medicines, including biologic therapies, vaccines and animal health products. The Company's segments include Pharmaceutical and Animal Health. Pharmaceutical segment includes human health pharmaceutical and vaccine products. The Company sells its human health pharmaceutical products primarily to drug wholesalers and retailers, hospitals, government agencies and managed health care providers. It sells its human health vaccines primarily to physicians, wholesalers, distributors and government entities. Animal Health segment discovers, develops, manufactures and markets a range of veterinary pharmaceutical and vaccine products, as well as health management solutions and services, for the prevention, treatment and control of disease in all major livestock and companion animal species. It sells its products to veterinarians, distributors, animal producers, farmers and pet owners.